These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23365420)

  • 21. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.
    Cao J; McNevin J; McSweyn M; Liu Y; Mullins JI; McElrath MJ
    J Virol; 2008 Jan; 82(1):495-502. PubMed ID: 17942528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.
    Miura T; Brockman MA; Brumme ZL; Brumme CJ; Pereyra F; Trocha A; Block BL; Schneidewind A; Allen TM; Heckerman D; Walker BD
    J Virol; 2009 Jan; 83(1):140-9. PubMed ID: 18971283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.
    Liu Y; McNevin J; Zhao H; Tebit DM; Troyer RM; McSweyn M; Ghosh AK; Shriner D; Arts EJ; McElrath MJ; Mullins JI
    J Virol; 2007 Nov; 81(22):12179-88. PubMed ID: 17728222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.
    Liu D; Zuo T; Hora B; Song H; Kong W; Yu X; Goonetilleke N; Bhattacharya T; Perelson AS; Haynes BF; McMichael AJ; Gao F
    Retrovirology; 2014 Nov; 11():101. PubMed ID: 25407514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.
    Yang OO; Sarkis PT; Ali A; Harlow JD; Brander C; Kalams SA; Walker BD
    J Exp Med; 2003 May; 197(10):1365-75. PubMed ID: 12743169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
    Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P
    J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variation.
    Honeyborne I; Codoñer FM; Leslie A; Tudor-Williams G; Luzzi G; Ndung'u T; Walker BD; Goulder PJ; Prado JG
    J Virol; 2010 Nov; 84(21):11279-88. PubMed ID: 20739527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.
    Wang YE; Li B; Carlson JM; Streeck H; Gladden AD; Goodman R; Schneidewind A; Power KA; Toth I; Frahm N; Alter G; Brander C; Carrington M; Walker BD; Altfeld M; Heckerman D; Allen TM
    J Virol; 2009 Feb; 83(4):1845-55. PubMed ID: 19036810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.
    Ganusov VV; Goonetilleke N; Liu MK; Ferrari G; Shaw GM; McMichael AJ; Borrow P; Korber BT; Perelson AS
    J Virol; 2011 Oct; 85(20):10518-28. PubMed ID: 21835793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
    Schneidewind A; Brockman MA; Sidney J; Wang YE; Chen H; Suscovich TJ; Li B; Adam RI; Allgaier RL; Mothé BR; Kuntzen T; Oniangue-Ndza C; Trocha A; Yu XG; Brander C; Sette A; Walker BD; Allen TM
    J Virol; 2008 Jun; 82(11):5594-605. PubMed ID: 18385228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.
    Peyerl FW; Bazick HS; Newberg MH; Barouch DH; Sodroski J; Letvin NL
    J Virol; 2004 Dec; 78(24):13901-10. PubMed ID: 15564498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.